Nicole Negar Davarpanah
Chief Medical Officer · Cidara Therapeutics, Inc.
IndividualSelling only
- 2025
- Sep 11, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Nicole Negar Davarpanah's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nicole Negar Davarpanah?
Nicole Negar Davarpanah is a corporate insider, tracked as Chief Medical Officer of Cidara Therapeutics, Inc. (CDTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Nicole Negar Davarpanah last file a Form 4?
The only primary Form 4 on record is dated 11 September 2025.
Has Nicole Negar Davarpanah been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($30K) across all tracked filings.
